HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fuxe, K. Articles by Ferré, S. Search for Related Content PubMed PubMed Citation Articles by Fuxe, K. Articles by Ferré, S.

Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.

Receptor heteromerization in adenosine A_2A receptor signaling

Relevance for striatal function and Parkinson’s disease

From the Department of Neuroscience (Drs. Fuxe, Torvinen, and Terasmaa), Karolinska Institute, Stockholm, Sweden; Biomedical Sciences (Drs. Agnati, Leo, and Vergoni), University of Modena, Italy; Department of Anatomy (Dr. Staines, K. Jacobsen and B. Tinner-Staines), University of Ottawa, Canada; Stroke Branch (Dr. Hillion), NINDS, NIH, Bethesda, MD; Department of Biochemistry and Molecular Biology (Drs. Lluis, Ciruela, and Franco, M. Canals), University of Barcelona, Spain; Department of Pharmacology (Dr. Rosin), University of Virginia Health Sciences Center, Charlottesville, VA; Department of Pharmacology (Dr. Popoli), Istituto Superiore di Sanita, Rome, Italy; and Pre-clinical Pharmacology Section (Dr. Ferré), Behavioral Neuroscience Branch, NIDA, NIH, IRP, Baltimore, MD.

Address correspondence and reprint requests to Dr. Kjell Fuxe, Department of Neuroscience, Karolinska Institutet, Retzius väg 8, A2:4, S17177, Stockholm, Sweden; e-mail: kjell.fuxe{at}neuro.ki.se

Recently evidence has been presented that adenosine A_2A and dopamine D₂ receptors form functional heteromeric receptor complexes as demonstrated in human neuroblastoma cells and mouse fibroblast Ltk^- cells. These A_2A/D₂ heteromeric receptor complexes undergo coaggregation, cointernalization, and codesensitization on D₂ or A_2A receptor agonist treatments and especially after combined agonist treatment. It is hypothesized that the A_2A/D₂ receptor heteromer represents the molecular basis for the antagonistic A_2A/D₂ receptor interactions demonstrated at the biochemical and behavioral levels. Functional heteromeric complexes between A_2A and metabotropic glutamate 5 receptors (mGluR5) have also recently been demonstrated in HEK-293 cells and rat striatal membrane preparations. The A_2A/mGluR5 receptor heteromer may account for the synergism found after combined agonist treatments demonstrated in different in vitro and in vivo models. D₂, A_2A, and mGluR5 receptors are found together in the dendritic spines of the striatopallidal GABA neurons. Therefore, possible D₂/A_2A/mGluR5 multimeric receptor complexes and the receptor interactions within them may have a major role in controlling the dorsal and ventral striatopallidal GABA neurons involved in Parkinson’s disease and in schizophrenia and drug addiction, respectively.

This article has been cited by other articles:

				K. Fuxe, D. Marcellino, D. Guidolin, A. S. Woods, and L. F. Agnati Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors Physiology, December 1, 2008; 23(6): 322 - 332. [Abstract] [Full Text] [PDF]

				A. Kachroo, L. R. Orlando, D. K. Grandy, J.-F. Chen, A. B. Young, and M. A. Schwarzschild Interactions between Metabotropic Glutamate 5 and Adenosine A2A Receptors in Normal and Parkinsonian Mice J. Neurosci., November 9, 2005; 25(45): 10414 - 10419. [Abstract] [Full Text] [PDF]

				M. S. Cowen, E. Djouma, and A. J. Lawrence The Metabotropic Glutamate 5 Receptor Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine Reduces Ethanol Self-Administration in Multiple Strains of Alcohol-Preferring Rats and Regulates Olfactory Glutamatergic Systems J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 590 - 600. [Abstract] [Full Text] [PDF]

				M. Torvinen, D. Marcellino, M. Canals, L. F. Agnati, C. Lluis, R. Franco, and K. Fuxe Adenosine A2A Receptor and Dopamine D3 Receptor Interactions: Evidence of Functional A2A/D3 Heteromeric Complexes Mol. Pharmacol., February 1, 2005; 67(2): 400 - 407. [Abstract] [Full Text] [PDF]

				D. L. Rosin, B. D. Hettinger, A. Lee, and J. Linden Anatomy of adenosine A2A receptors in brain: Morphological substrates for integration of striatal function Neurology, December 9, 2003; 61(90116): S12 - 18. [Abstract] [Full Text]